Bionano Genomics (NASDAQ:BNGO) Trading Up 5.5% – Still a Buy?

Bionano Genomics, Inc. (NASDAQ:BNGO)’s stock price traded up 5.5% on Wednesday . The stock traded as high as $5.36 and last traded at $5.35. 165,486 shares changed hands during trading, a decline of 52% from the average session volume of 341,812 shares. The stock had previously closed at $5.07.

Analyst Ratings Changes

Separately, LADENBURG THALM/SH SH cut Bionano Genomics from a “buy” rating to a “neutral” rating in a research report on Friday, November 15th.

Bionano Genomics Trading Up 1.3 %

The stock has a market cap of $600.38 million, a P/E ratio of -2.21 and a beta of 2.22. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 0.99. The business’s 50 day simple moving average is $13.26 and its 200 day simple moving average is $21.55.

Institutional Trading of Bionano Genomics

Several hedge funds have recently modified their holdings of the stock. Carret Asset Management LLC boosted its position in Bionano Genomics by 89.0% in the 3rd quarter. Carret Asset Management LLC now owns 85,055 shares of the company’s stock valued at $39,000 after buying an additional 40,055 shares during the last quarter. GSA Capital Partners LLP bought a new position in Bionano Genomics in the third quarter valued at about $46,000. Finally, Geode Capital Management LLC increased its position in Bionano Genomics by 47.3% in the third quarter. Geode Capital Management LLC now owns 882,854 shares of the company’s stock worth $401,000 after purchasing an additional 283,639 shares during the period. 11.35% of the stock is owned by institutional investors.

Bionano Genomics Company Profile

Bionano Genomics, Inc provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA.